Teresa P. DiLorenzo
Affiliations: | Yeshiva University, New York, NY, United States |
Area:
Immunology, Cell Biology, PathologyGoogle:
"Teresa DiLorenzo"Children
Sign in to add trainee| Adam S. Buntzman | grad student | 2006 | Yeshiva University |
| Irene Jarchum | grad student | 2009 | Yeshiva University |
| Jeffrey Babad | grad student | 2014 | Yeshiva University |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| White TD, Almutairi A, Gai-Tusing Y, et al. (2024) Differential lipid signaling from CD4 and CD8 T cells contributes to type 1 diabetes development. Frontiers in Immunology. 15: 1444639 |
| Sharma R, Amdare NP, Ghosh A, et al. (2024) Structural and biochemical analysis of highly similar HLA-B allotypes differentially associated with type 1 diabetes. The Journal of Biological Chemistry. 107702 |
| Amdare NP, Shultz LD, Greiner DL, et al. (2024) Human insulin as both antigen and protector in type 1 diabetes. European Journal of Immunology. e2350949 |
| Gearty SV, Dündar F, Zumbo P, et al. (2021) An autoimmune stem-like CD8 T cell population drives type 1 diabetes. Nature |
| Amdare N, Purcell AW, DiLorenzo TP. (2021) Non-contiguous T cell epitopes in autoimmune diabetes: From mice to men and back again. The Journal of Biological Chemistry. 100827 |
| James EA, Mallone R, Kent SC, et al. (2020) T-Cell Epitopes and Neo-epitopes in Type 1 Diabetes: A Comprehensive Update and Reappraisal. Diabetes. 69: 1311-1335 |
| Schloss J, Ali R, Babad J, et al. (2019) Development and Characterization of a Preclinical Model for the Evaluation of CD205-Mediated Antigen Delivery Therapeutics in Type 1 Diabetes. Immunohorizons. 3: 236-253 |
| Purcell AW, Sechi S, DiLorenzo TP. (2019) The Evolving Landscape of Autoantigen Discovery and Characterization in Type 1 Diabetes. Diabetes. 68: 879-886 |
| Schloss J, Ali R, Racine JJ, et al. (2018) HLA-B*39:06 Efficiently Mediates Type 1 Diabetes in a Mouse Model Incorporating Reduced Thymic Insulin Expression. Journal of Immunology (Baltimore, Md. : 1950) |
| Racine JJ, Stewart I, Ratiu J, et al. (2018) Improved Murine-MHC-Deficient HLA-Transgenic NOD-Mouse Models for Type 1 Diabetes Therapy Development. Diabetes |